When was JUMPCODE Genomics founded?

JUMPCODE Genomics was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is JUMPCODE Genomics located?

JUMPCODE Genomics is headquartered in Carlsbad, United States. It is registered at 4755 Nexus Center Drive Suite 100 San Diego, CA 92121.

How many employees does JUMPCODE Genomics have?

As of Aug 31, 2026, the latest employee count at JUMPCODE Genomics is 7.

Is JUMPCODE Genomics a funded company?

JUMPCODE Genomics is a funded company, having raised a total of $38.7M across 7 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Sep 12, 2018.

When was the latest funding round of JUMPCODE Genomics?

JUMPCODE Genomics' latest funding was a $***** Grant (prize money) round on Dec 16, 2025, with participation from 1 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $2.31B in funding in 2026 to date.

Where does JUMPCODE Genomics rank among its competitors?

JUMPCODE Genomics ranks 22nd amongst 209 active competitors, of which 38 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Sebia, which secured an undisclosed amount in May, 2026.

Who are the top competitors of JUMPCODE Genomics?

JUMPCODE Genomics' top competitors include Qiagen, Parse Biosciences and Integrated DNA Technologies. Among them, Sebia secured the most recent funding round in May, 2026.

JUMPCODE Genomics - 2026 Company Profile, Funding & Competitors

Company Details

JumpCode provides technology for depleting unwanted nucleic acid. The CRISPRclean is a proprietary technology that utilizes the CRISPR/CAS system to deplete unwanted nucleic acid molecules from sequencing libraries. The applications of the technology include host organism depletion, ribosomal RNA depletion, repetitive sequence depletion, allele-specific depletion, and others. The patented CRISPRclean technology allows the researcher to remove unwanted regions. The company provides products for RNA depletion suing the rRNA depletion kits or DNA depletion using the companies DNA Depletion kit.

Website: jumpcodegenomics.com
Social
Registered Address: 4755 Nexus Center Drive Suite 100 San Diego, CA 92121

Key Metrics

Founded Year

2016

Location

Carlsbad, United States

Stage

Series B

Total Funding

$38.7M in 7 rounds

Latest Funding Round

Grant (prize money), Dec 16, 2025, $*****

Investors

Baird Capital & 3 more

Ranked

22^nd among 209 active competitors

Employee Count

7 as on Aug 31, 2026

Similar Companies

Qiagen & 279 more

View JUMPCODE Genomics' full profile

JUMPCODE Genomics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Jumpcode Genomics, Inc. CIN: 81-4372927 , United States, Active	Nov 08, 2016	-	27 (As on Dec 31, 2021)	-

JUMPCODE Genomics has raised a total funding of $38.7M over 7 rounds. Its first funding round was on Sep 12, 2018. Its latest funding round was a Grant (prize money) round on Dec 16, 2025 for $*****. 1 investor participated in its latest round. JUMPCODE Genomics has 4 institutional investors.

Here is the list of recent funding rounds of JUMPCODE Genomics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 16, 2025	7813479	Grant (prize money)	2693020	2631751	2191162	4760375
Feb 24, 2025	6405526	Grant (prize money)	5442270	4114736	3114025	HHS
Aug 15, 2024	6475332	Series B	5195507	6599415	6910490	4932924

Access funding benchmarks and valuations. Sign up today!

View details of JUMPCODE Genomics's funding rounds and investors

JUMPCODE Genomics' employee count trend

JUMPCODE Genomics has 7 employees as of Aug 26. Here is JUMPCODE Genomics's employee count trend over the years:

Employee count trend for JUMPCODE Genomics

Uncover JUMPCODE Genomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of JUMPCODE Genomics include Qiagen, Parse Biosciences and Integrated DNA Technologies. Here is the list of Top 10 competitors of JUMPCODE Genomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Qiagen 1984, Venlo (Netherlands), Acquired	Provider of products and reagents for molecular diagnostic assays	-	Life Sciences Partners, Harmonic & 6 others	65/100
2nd	Parse Biosciences 2018, Seattle (United States), Series C	Developer of RNA-sequencing solution-based transcriptome kit to analyze health data	$100M	Marshall Wace, Janus Henderson Investors & 8 others	64/100
3rd	Integrated DNA Technologies 1987, Coralville (United States), Acquired	Provider of oligonucleotide-based reagents and kits	-	Summit Partners, Golub Capital & 1 others	63/100
4th	RareCyte 2009, Seattle (United States), Series C	Developer of technologies for the analysis of rare and single cells in the blood	$114M	Arboretum Ventures, Health Quest Capital ... & 11 others	57/100
5th	Neogen 1982, Lansing (United States), Acquired	Solutions for food and animal safety, diagnostics, and genomics	$700K	Innovative Ventures, NISA	56/100
6th	Sebia 1967, Evry Courcouronnes (France), Acquired	Developer of electrophoresis-based in vitro diagnostics products	-	Warburg Pincus, HarbourVest Partners & 5 others	56/100
7th	Genomtec 2016, Wroclaw (Poland), Series A	Provider of handheld POC device for nucleic acid testing	$4.38M	KnowledgeHub, EIC Fund & 5 others	55/100
8th	NuProbe 2016, George Town (Cayman Islands), Series B	Develops sensitive multiplex tool for QPCR	$61M	Sequoia Capital, Yonghua Capital & 14 others	51/100
9th	Novacyt 2005, Velizy Villacoublay (France), Public	A molecular diagnostics company specializing in genomic medicine solutions	-	Kreos Capital, Eiffel Investment Group & 2 others	50/100
10th	Fluent BioSciences 2018, Watertown (United States), Acquired	Developer of reagent for DNA analysis for genetic analysis	$19M	Illumina Ventures, Samsara BioCapital & 6 others	48/100
22nd	JUMPCODE Genomics 2016, Carlsbad (United States), Series B	Provider of a technology for depleting unwanted nucleic acid	$38.7M	Baird Capital, Arboretum Ventures & 2 others	41/100